|
| 38049564 | MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression. | Oncogene | 2024 |
| 36346110 | Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma. | Int J Cancer | 2023 |
| 37958555 | Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Int J Mol Sci | 2023 |
| 37523146 | High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer. | Cancer Res | 2023 |
| 37511646 | Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial. | J Pers Med | 2023 |
| 37726477 | Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives. | Br J Cancer | 2023 |
| 37060785 | Pyrimido[1,2-a]benzimidazoles as inhibitors of oncoproteins ubiquitin specific protease 5 and MYCN in the childhood cancer neuroblastoma. | Bioorg Chem | 2023 |
| 36980710 | Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface. | Cancers (Basel) | 2023 |
| 37382186 | Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial. | Cancer | 2023 |
| 37013636 | A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer. | Genome Med | 2023 |
| 37105227 | Impact of Hospitalizations due to Chronic Health Conditions on Early Child Development. | J Pediatr Psychol | 2023 |
| 37376781 | Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine. | Cancer | 2023 |
| 36656928 | Heritable defects in telomere and mitotic function selectively predispose to sarcomas. | Science | 2023 |
| 34297633 | "We Have All This Knowledge to Give, So Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research Priorities. | J Adolesc Young Adult Oncol | 2022 |
| 36109702 | Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia. | BMC Cancer | 2022 |
| 36198269 | Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. | Cell Rep | 2022 |
| 36013276 | What's in a Name? Parents' and Healthcare Professionals' Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes. | J Pers Med | 2022 |
| 36048846 | It's made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illness. | PLoS One | 2022 |
| 33567813 | Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. | Haematologica | 2022 |
| 34998954 | miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma. | Mol Ther | 2022 |
| 34471258 | Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma. | Br J Cancer | 2022 |
| 34806212 | Inequality in early childhood chronic health conditions requiring hospitalisation: A data linkage study of health service utilisation and costs. | Paediatr Perinat Epidemiol | 2022 |
| 34475105 | School academic performance of children hospitalised with a chronic condition. | Arch Dis Child | 2022 |
| 33310889 | Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy. | Clin Cancer Res | 2021 |
| 33767157 | An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. | Nat Commun | 2021 |
| 33620089 | CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia. | Br J Haematol | 2021 |
| 33895784 | Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia. | Leukemia | 2021 |
| 33918978 | A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. | Cancers (Basel) | 2021 |
| 33580196 | Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor. | NPJ Precis Oncol | 2021 |
| 33658627 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma. | Oncogene | 2021 |
| 34641289 | Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer Cells. | Molecules | 2021 |
| 34638267 | MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. | Cancers (Basel) | 2021 |
| 34826366 | A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma. | Curr Protoc | 2021 |
| 33994371 | Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. | Clin Cancer Res | 2021 |
| 34230493 | Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia. | Nat Commun | 2021 |
| 31841257 | The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients. | Intern Med J | 2021 |
| 33403751 | School and educational support programmes for paediatric oncology patients and survivors: A systematic review of evidence and recommendations for future research and practice. | Psychooncology | 2021 |
| 32197360 | Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC Inhibitors. | Molecules | 2020 |
| 31876116 | Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia. | Pediatr Blood Cancer | 2020 |
| 32086952 | Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma. | Int J Cancer | 2020 |
| 31865525 | Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype. | J Clin Immunol | 2020 |
| 32075154 | "Balancing Expectations with Actual Realities": Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial. | J Pers Med | 2020 |
| 33144287 | Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumors. | Cold Spring Harb Mol Case Stud | 2020 |
| 33184347 | Withaferin A activates TRIM16 for its anti-cancer activity in melanoma. | Sci Rep | 2020 |
| 32801162 | Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in <i>CRLF2</i>-Rearranged Ph-like ALL. | Mol Cancer Res | 2020 |
| 32684628 | CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma. | Br J Cancer | 2020 |
| 32952126 | A structural view of PA2G4 isoforms with opposing functions in cancer. | J Biol Chem | 2020 |
| 32502332 | Prevalence, hospital admissions and costs of child chronic conditions: A population-based study. | J Paediatr Child Health | 2020 |
| 32438682 | Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian Children. | Cancers (Basel) | 2020 |
| 32536690 | Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia. | Br J Cancer | 2020 |